心肌T1与T2映射:技术与临床应用
本文综述了心脏磁共振T1与T2映射序列技术及其临床应用。T1、T2及细胞外容积分数(ECV)可定量心肌组织特征,已成为心肌病诊断的生物标志物及治疗监测和预后预测因素,相关序列正逐步融入常规心脏磁共振检查。
要点
- T1、T2及ECV映射可直接定量心肌组织特性,是心肌病诊断的可靠生物标志物。
- 这些定量参数还可用于治疗监测和预后预测。
- T1与T2映射序列技术快速发展,正逐步整合进常规心脏磁共振流程。
核心结论
- T1、T2和ECV值目前被认为是诊断心肌病的可靠生物标志物,同时也是治疗监测和预后预测的因素。
研究设计与样本
- 综述,回顾了多种T1与T2映射序列技术及其临床应用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging in recent times have resulted in the development of new techniques for CMR imaging. T1 and T2 image mapping sequences enable the direct quantification of T1, T2, and extracellular volume fraction (ECV) values of the myocardium, leading to the progressive integration of these sequences into routine CMR settings. Currently, T1, T2, and ECV values are being recognized as not only robust biomarkers for diagnosis of cardiomyopathies, but also predictive factors for treatment monitoring and prognosis. In this study, we have reviewed various T1 and T2 mapping sequence techniques and their clinical applications.
引用
- Kim PK, Hong YJ, Im DJ, et al. Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol. 2017. PMID: 28096723. doi:10.3348/kjr.2017.18.1.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。